Neurocognitive aspects of brain metastasis
Related Experiment Video
Updated: Feb 16, 2026

Coherence between Brain Cortical Function and Neurocognitive Performance during Changed Gravity Conditions
Published on: May 23, 2011
Jeffrey S Wefel1, Michael W Parsons2, Vinai Gondi3
1Section of Neuropsychology, Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Abstract:
Brain metastases are common, occurring in approximately 20% of cancer patients. One of the biggest concerns for these patients and their families is neurocognitive decline. Neurocognitive issues in this patient population are complex and many patients have neurocognitive impairment due to systemic therapies even before they develop brain metastases. The development of brain metastases as well as the treatment of these tumors can cause decline in neurocognitive function. Diffuse treatments such as whole-brain radiotherapy are more frequently associated with neurocognitive decline than focal interventions such as radiosurgery, surgical resection, and implantable chemotherapy wafers. For patients with brain metastases treatment decisions require a multidisciplinary approach, balancing many factors including the neurocognitive impact of treatment and the disease process itself. Finally, to continue to advance the field there needs to be continued utilization, both off and on clinical trial, of performance-based clinical outcome assessments (i.e., neurocognitive tests) to objectively assess and measure the neurocognitive outcomes of these patients.
Insights
Brain metastases impact neurocognition, with diffuse treatments like whole-brain radiotherapy causing more decline than focal interventions. Objective neurocognitive testing is crucial for managing brain tumor patients.
Area of Science:
- Neuro-oncology
- Cancer patient care
Background:
- Brain metastases affect ~20% of cancer patients.
- Neurocognitive decline is a major concern, often pre-existing due to systemic therapies.
- Both brain metastases and their treatments can worsen cognitive function.
Purpose of the Study:
- To analyze the neurocognitive impact of brain metastases and their treatments.
- To highlight the complexity of neurocognitive issues in this patient population.
- To emphasize the need for multidisciplinary decision-making regarding treatment choices.
Main Methods:
- Review of treatment modalities for brain metastases.
- Comparison of neurocognitive outcomes associated with different treatment approaches.
- Discussion of the role of clinical outcome assessments.
Main Results:
- Diffuse treatments (e.g., whole-brain radiotherapy) are more strongly linked to neurocognitive decline than focal interventions (e.g., radiosurgery, surgery).
- Treatment decisions require balancing efficacy with neurocognitive impact.
- Performance-based neurocognitive tests are essential for objective outcome measurement.
Conclusions:
- Multidisciplinary care is vital for managing brain metastases and their neurocognitive effects.
- Focal treatments may offer a better neurocognitive profile compared to diffuse therapies.
- Standardized neurocognitive assessments are necessary to advance patient care and research.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Quantitative Aspects of Drug-Receptor Interaction
Brain Waves
Organization of the Brain
Hindbrain
The hindbrain, located at the base of the brain, plays a vital role in regulating automatic processes that sustain life. It includes the medulla oblongata, which is essential for...
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
The Blood-brain Barrier

